Genetic knockout and pharmacologic inhibition of NCX1 attenuate hypoxia-induced pulmonary arterial hypertension.
Genetic knockout and pharmacologic inhibition of NCX1 attenuate hypoxia-induced pulmonary arterial hypertension.
复制标题
NCX1 的基因敲除和药物抑制可减轻缺氧引起的肺动脉高压。
DOI:
10.1016/j.bbrc.2020.06.045
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Iwamoto T.
中科院分区:
文献类型:
--
作者:
1.Nagata A;Tagashira H;Kita S;Kita T;Nakajima N;Abe K;Iwasaki A;Iwamoto T.
The Na+/Ca2+exchanger type-1 (NCX1) is a bidirectional transporter that is controlled by membrane potential and transmembrane gradients of Na+and Ca2+. Vascular smooth muscle NCX1 plays an important role in intracellular Ca2+homeostasis and Ca2+signaling. We found that NCX1 was upregulated in the pulmonary arteries of mice exposed to chronic hypoxia (10% O2for 4 weeks). Hence, we investigated the pathophysiological role of NCX1 in hypoxia-induced pulmonary arterial hypertension (PAH), using NCX1-heterozygous (NCX1+/−) mice, in which NCX1 expression is reduced by half, and SEA0400, a specific NCX1 inhibitor. NCX1+/−mice exhibited attenuation of hypoxia-induced PAH and right ventricular (RV) hypertrophy compared with wild-type mice. Furthermore, continuous administration of SEA0400 (0.5 mg/kg/day for 4 weeks) to wild-type mice by osmotic pumps significantly suppressed hypoxia-induced PAH and pulmonary vessel muscularization, with a slight reduction in RV hypertrophy. These findings indicate that the upregulation of NCX1 contributes to the development of hypoxia-induced PAH, suggesting that NCX1 inhibition might be a novel approach for the treatment of PAH.
登录
查看更多内容
影响因子:
4.8
作者:
Wakimoto, K;Kobayashi, K;Komuro, I
通讯作者:
Komuro, I
影响因子:
5.5
作者:
Zhang, Shen;Dong, Hui;Yuan, Jason X. -J.
通讯作者:
Yuan, Jason X. -J.
DOI:
10.1073/pnas.0405908101
发表时间:
2004-09-21
影响因子:
11.1
作者:
Yu, Y;Fantozzi, L;Yuan, JXJ
通讯作者:
Yuan, JXJ
影响因子:
20.1
作者:
Dierick, France;Hery, Tiphaine;Nadaud, Sophie
通讯作者:
Nadaud, Sophie